BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34013371)

  • 1. Noncoding RNAs as key modulators of autophagy in pancreatic cancer (Review).
    Mukherjee M; Pramanick S; Saha B; Chhatriya B; Goswami S
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
    Jiang PC; Bu SR
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):511-516. PubMed ID: 31610988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of autophagy and its regulation by noncoding RNAs in ovarian cancer.
    Feng C; Yuan X
    Exp Biol Med (Maywood); 2023 Jun; 248(12):1001-1012. PubMed ID: 36803116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of Autophagy-Related MicroRNAs.
    Ozturk DG; Kocak M; Gozuacik D
    Methods Mol Biol; 2019; 1854():131-146. PubMed ID: 29022289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
    Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
    Garajová I; Balsano R; Tommasi C; Giovannetti E
    Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
    Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
    Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p.
    Liu C; Wang JO; Zhou WY; Chang XY; Zhang MM; Zhang Y; Yang XH
    Mol Cell Endocrinol; 2019 Aug; 493():110424. PubMed ID: 30991076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
    Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
    BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis.
    Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J
    Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA.
    Li X; Li Z; Zhu H; Yu X
    Biomed Res Int; 2020; 2020():8537381. PubMed ID: 33204717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
    Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
    Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer.
    Robless EE; Howard JA; Casari I; Falasca M
    Cancer Lett; 2021 Mar; 501():55-65. PubMed ID: 33359452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.
    Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B
    Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing.
    Zhang L; Yu S; Wang C; Jia C; Lu Z; Chen J
    Int J Oncol; 2018 Dec; 53(6):2659-2670. PubMed ID: 30221677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
    Peng L; Sang H; Wei S; Li Y; Jin D; Zhu X; Li X; Dang Y; Zhang G
    Mol Cancer; 2020 Nov; 19(1):156. PubMed ID: 33153478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity.
    Ashrafizadeh M; Zarrabi A; Orouei S; Kiavash Hushmandi ; Hakimi A; Amirhossein Zabolian ; Daneshi S; Samarghandian S; Baradaran B; Najafi M
    Eur J Pharmacol; 2021 Feb; 892():173660. PubMed ID: 33310181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.